Ravi Gupta and colleagues argue that we need to reconsider standards for targeted pharmaceutical marketing to doctors through speaker programmes, consulting programmes, and advisory board positions.
In this scoping review, we evaluated the performance of artificial intelligence
(AI) in clinical radiology practice and examined health professionals' perspectives regarding AI use in radiology.